Why BGPT?
logo

Review Papers Claim by Claim

Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to start review


     Quick Explanation



    iNKT and MAIT Cell Alterations in Diabetes (Magalhaes, Kiaf & Lehuen, Frontiers in Immunology, 2015) is a well-cited narrative review that integrates iNKT cell defects in T1D/T2D with emerging MAIT cell data in obesity, and hypothesizes a microbiota–immune axis


     Long Explanation



    Evidence Base and Core Claims

    This 2015 review (Magalhaes, Kiaf & Lehuen, Institut Cochin) synthesizes iNKT and MAIT cell alterations across T1D, T2D and obesity, drawing heavily on the authors' own primary work including their J Clin Invest study showing MAIT cell frequency reductions, increased IL-17 production, and adipose tissue retention in obese/T2D patients . For iNKT cells, the review correctly highlights NOD mouse protective mechanisms via IL-4/IL-10 and Treg induction, while transparently acknowledging that human T1D data are contradictory .

    Schematic derived from qualitative claims in the review text; exact numeric values for obese adult vs lean MAIT frequencies are not reported in the review itself β€” this is an interpretive illustration, not measured data.

    Strengths

    • Timely integration of two unconventional T cell lineages with metabolism
    • Honest acknowledgment of contradictory human iNKT data
    • Forward-looking microbiota hypothesis now partly supported by later work showing archaeal riboflavin drives MAIT responses
    • No declared conflicts of interest; public funding (INSERM, CNRS, ANR, FRM)

    Limitations and Blind Spots

    • Species over-generalization: NOD mouse iNKT biology does not reliably translate to human T1D; the review acknowledges this but does not quantify the discordance
    • Causality not established: Whether MAIT depletion drives insulin resistance or reflects it remains unresolved β€” the authors' own bariatric surgery data show partial restoration but persistent Th17 skewing at 12 months
    • Cohort heterogeneity: Obese children showed increased MAIT frequency with hyperinsulinemia, opposite to adults β€” a key confounder inadequately explored
    • No mechanistic depth on microbiota–MAIT axis: The hypothesis is plausible but the review offers no direct experimental evidence linking specific microbial metabolites to MAIT cell alteration in metabolic disease
    • Publication bias risk: The review does not discuss negative studies or failed replication attempts in the iNKT–T1D literature systematically

    How Future Work Changed the Picture

    Subsequent studies confirmed MAIT alterations in metabolic contexts but revealed complexity: obese children show increased MAIT frequency , and microbiota-MAIT links involve archaeal rather than primarily bacterial sources, which the original review did not anticipate .

    Confidence and Falsifiability

    Confidence in the review's synthesis: Moderate. The MAIT–obesity association is well-supported by primary data; the iNKT–T1D protective mechanism in mice is robust but human relevance remains uncertain. The microbiota hypothesis is testable: it would be falsified if microbiota manipulation in T1D/T2D models fails to alter iNKT/MAIT frequency or if microbiota changes are shown to be consequences rather than causes of metabolic inflammation.



    Feedback:    

    Updated: October 08, 2026



     BGPT Paper Review



    Study Novelty

    70%

    First review to co-synthesize iNKT and MAIT cell defects across both T1D and T2D with a microbiota-immunometabolism framework, published at a time when MAIT cell data in metabolic disease were nascent.



    Scientific Quality

    60%

    Well-structured narrative review with transparent discussion of contradictory data and appropriate caveats; however, it is not a systematic review, cites primarily the authors' own work for MAIT claims, and offers no quantitative meta-analysis or pre-registered search strategy.



    Study Generality

    70%

    Bridges immunology, metabolism, and microbiome science with implications beyond diabetes (obesity, inflammation, mucosal immunity), though the core focus remains disease-specific.



    Study Usefulness

    70%

    Valuable conceptual roadmap that stimulated subsequent research into MAIT-metabolism links and microbiota modulation; practical utility limited by lack of therapeutic recommendations.



    Study Reproducibility

    40%

    As a narrative review with no search methodology, no quantitative synthesis, and no data deposition, reproducibility is inherently low; primary underlying studies are separately assessable.



    Explanatory Depth

    60%

    🎁 Authors: Collect 98 Free Science Tokens (β‰ˆ $9.8 USD)

    Claim My Author Tokens

    Use for 24 days of free BGPT access (4 tokens = 1 day) or trade/sell (β‰ˆ $9.8 USD)

     Top Data Sources ExportMCP



     Hypothesis Graveyard



    iNKT cell numerical deficiency is a universal hallmark of human T1D: falsified by multiple studies showing no difference or even increased frequencies, and by the recognition that subset composition (iNKT17 enrichment) matters more than total cell number.


    Gut bacterial riboflavin is the primary driver of circulating MAIT cell abundance: challenged by 2026 metagenomic evidence that archaeal riboflavin pathway abundance, not bacterial, correlates with MAIT frequency and activation.

     Science Art


    Paper Review: iNKT and MAIT Cell Alterations in Diabetes Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT